Abstract: Objective: The present study aimed
to evaluate the clinical value of minimally invasive surgery for intracranial
hematoma removal and high intracranial pressure (ICP) reduction using a novel
three-needle brain puncture technique.
Methods: A total of 202 cases with
supratentorial hematoma were analyzed, 54 of whom received three-needle brain
puncture (study group), and the remaining cases received single-needle (control
groups 1 and 2) and two-needle brain puncture (control group 3). The amount of
intracranial hematoma removed, changes in ICP, retention time of puncture
needle, volume of residual blood, the National Institute of Health Stroke Scale
(NIHSS) score, and postoperative survival rate were used as indexes to evaluate
patient outcomes.
Results: We found that
three-needle brain puncture (study group) can remove more intracranial hematoma
(p<0.05)
and achieve lower ICP (p<0.05) than single- and two-needle brain puncture (control group).
The needle retention time and volume of residual blood significantly decreased
in the study group. Additionally, a statistically significant difference was
observed in the NIHSS scores and survival rates between the study and control
groups (p<0.05).
Conclusion: These data suggest that
three-needle minimally invasive stereotactic puncture can effectively remove
hematoma, reduce ICP, decrease the degree of brain damage, and improve
prognosis.
